Weill Cornell Medical College

Gastroenterology Research Directory

Brian P. Bosworth, MD

Assistant Professor of Medicine

Email: [email protected]

Tel: 212-746-5077

 

At the Roberts Center for Inflammatory Bowel Disease, we actively welcome and encourage housestaff participation in our clinical and translational investigations. We have opportunities for residents to engage in all aspects of IBD related research from prospective trials of biomarker evaluation or pharmacological intervention, to chart reviews. We also have projects involving basic science and animal work with our colleagues at Rockefeller and MSKCC on both the immunologic and microbiologic etiopathogenesis of IBD. 

Recent Residents Mentored:  Alyssa Parian, Himanshu Verma, Raja Taunk, Subha Sundararajan, Yasmin Metz, Frank Scott, Robin Mendelsohn.

Carl V. Crawford, MD

Assistant Professor of Medicine

Email:[email protected]

Tel: 646-962-4000

I have several areas of interest.  My main areas of research focus on C. difficile and enteric infections on specific patient populations (IBD patients, leukemia/BMT populations, and the elderly).  I am also currently working with residents on the role of technology on colon polyp detection rates and the role of phytochemicals in the prevention of certain GI diseases.  There are opportunities for residents to engage in lab work, chart reviews and prospective studies as well as designing any studies they may have in mind related to the above areas.

Recent Residents and Fellows Mentored:  Lianne Cavelle, Nikhil Kumta, Valerie Antoine-Gustave, Yasmin Metz, Manan Shah and Ann Marie Liapakis. 

 

Andrew Dannenberg, MD

Professor of Medicine; Director of Cancer Center

Email: [email protected]

Tel: 212-746-4403

Our main research focus is defining the mechanism by which chronic inflammation predisposes to cancer, with the long-term goal of developing strategies to reduce risk. Studies are underway that focus on obesity, smoking, hereditary cancer, inflammatory bowel disease, and nutrigenomics. The potential use of metabolomics for biomarker development is also being investigated.

Maya Gambarin-Gelwan, MD

Assistant Professor of Medicine

Email: [email protected]

Tel: 646-962-4040

I would be very interested in working on research opportunities with our residents. Current research projects involve patients with non-alcoholic liver disease and chronic hepatitis C and liver cancer. I would like to develop a project with motivated residents, collaborating with the renal group, to study the effects of chronic HCV infection on the outcomes of renal transplantation, including non-liver related long-term complications.

Ira Jacobson, MD

Professor of Medicine; Chief, Division of Gastroenterology & Hepatology

Email: [email protected]

Tel: 646-962-4040

Clinical research projects involve viral hepatitis and other forms of liver disease. Opportunities for projects for residents include: (1) prevalence of HBV markers in patients with HCV-related liver cancer; (2) decline in platelet count as a marker of liver fibrosis; (3) renal effects of antiviral agents for hepatitis.

Ype P. de Jong, MD, PhD
Assistant Professor of Medicine
Email: [email protected], [email protected]
Tel: 212-327-7085

My research interest is to study how hepatitis C virus (HCV) evades the immune system. HCV only infects human hepatocytes and there currently exists a paucity of model systems. In the laboratory of Dr. Charles Rice at Rockefeller I am working on improving an in vivo HCV infection system, that consists of transplanting human hepatocytes into mice. Projects on which I would welcome Residents to participate include: (1) generation and in vitro characterization of innate immune-modifying lentiviral vectors; (2) transplantation optimization of human hepatocytes into different liver injury mouse lines; (3) treatment trials of new direct acting antivirals in mice. 

Steven Lipkin, MD, PhD

Associate Professor of Medicine
Email: [email protected]
Tel: 212-774-7160

 

My overall goal is to understand the fundamental basis of colorectal cancer and inflammatory bowel disease and effectively translate new knowledge from my own lab and others to improve chemoprevention, early detection and therapy. Methodologically, I use human and mouse genetics, cell based studies of signal transduction and computational approaches to achieve these goals.

Ellen J. Scherl, MD

Associate Clinical Professor of Medicine; Director, Roberts IBD Center

Email: [email protected]

Tel: 212-746-5077

We are delighted to work with residents on developing individual projects. Current projects include: (1) Crohn’s disease-associated NOD2 mutant regulation of IL-10 gene expression (with Dr. Ma); (2) characterization of mucosa-associated bacterial flora in inflammatory bowel disease (IBD); (3) inflammatory markers and mediators in GI inflammation; (4) pregnancy and neonatal outcomes and complications in preclinical IBD; (5) enzymatic determinants of prostaglandin levels in colonic mucosa (with Dr. Dannenberg), and others.

Felice Schnoll-Sussman, MD

Assistant Professor of Medicine

Email: [email protected]

 

Clinical research at the Monahan Center in the field of screening and prevention of gastrointestinal malignancies. Active trials include chemoprevention of Barrett’s esophagus and pancreatic cyst neoplasms, early detection of familial pancreatic cancer, and public outreach initiatives for colorectal cancer screening.

Recent Residents Mentored: Roberto Gonzalez, Lianne Cavell.

Andrew H. Talal, MD

Associate Professor of Medicine

Email: [email protected]

Tel: 212-746-4495

I wish to volunteer to be a mentor to residents. Laboratory is investigating hepatitis C virus (HCV) pathogenesis focusing on the role of the CXCR3-associated chemokines as mediators of hepatic inflammation and as potential biomarkers of hepatic fibrosis. Also investigating methods to engage disenfranchised populations with high prevalence of HCV infection (e.g. on methadone maintenance) into treatment. 

 

MSKCC GASTROENTEROLOGY AND NUTRITION  

Arnold Markowitz, MD

Email: [email protected]

Tel: 212-639-2901

        

Hereditary colorectal cancer 

Sidney Winawer, MD

Email: [email protected] 

Tel: 212-639-7678

             

Association of adenomas and family history of colorectal cancer with Hyperplastic Polyposis; correlation of family history with screening colonoscopy outcomes; international survey of colorectal cancer screening, physician anD public perceptions of risk and benefit, personal and systems barriers.  

Emmy Ludwig, MD/Robert Kurtz, MD

Email: [email protected]; [email protected] 

Tel: 212-639-2766, 212-639-7620

        

Family pancreatic cancer registry; hepatitis B reactivation prevention.  

Christopher DiMaio, MD

Email: [email protected]  

Tel: 212-639-2210

Role of EUS, ERCP, and stenting (biliary, pancreatic, esophagus, small bowel, colon) in management of patients with GI malignancies. Evaluation and development of minimally-invasive diagnostic and therapeutic endoscopic modalities for patients with gastrointestinal malignancies.  Examples of such modalities include the identification of biomarkers for the diagnosis of pre-malignant and malignant lesions; use of direct endoscopic-guided ablation of gastrointestinal tumors; development of new techniques in the management of malignant obstruction of the GI tract and pancreatico-biliary tree.